{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:32:35Z","timestamp":1790821955418,"version":"4.1.0"},"reference-count":310,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jconrel.2024.06.002","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T08:56:23Z","timestamp":1719478583000},"page":"494-521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Current status of mannose receptor-targeted drug delivery for improved anti-HIV therapy"],"prefix":"10.1016","volume":"372","author":[{"given":"Satish","family":"Rojekar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amol D.","family":"Gholap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namdev","family":"Togre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Bhoj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clement","family":"Haeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navnath","family":"Hatvate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyotsna","family":"Vitore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagar","family":"Dhoble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snehal","family":"Kashid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandana","family":"Patravale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2024.06.002_bb0005","series-title":"THE GLOBAL HEALTH OBSERVATORY: Explore a world of health data","author":"World Health Organization","year":"2023"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejpb.2021.04.024","article-title":"Etravirine-loaded dissolving microneedle arrays for long-acting delivery","volume":"165","author":"Rojekar","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0015","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.3390\/polym14153090","article-title":"Novel nanotechnology-based approaches for targeting HIV reservoirs","volume":"14","author":"Fotooh Abadi","year":"2022","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0020","article-title":"Tenofovir alafenamide fumarate loaded long-acting microsphere for HIV pre-exposure prophylaxis","volume":"87","author":"Pawar","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0025","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41591-023-02213-x","article-title":"In-depth virological and immunological characterization of HIV-1 cure after CCR5\u039432\/\u039432 allogeneic hematopoietic stem cell transplantation","volume":"29","author":"Jensen","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0030","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.cell.2023.02.030","article-title":"HIV-1 remission and possible cure in a woman after haplo-cord blood transplant","volume":"186","author":"Hsu","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0035","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s40121-018-0201-6","article-title":"A review of long-term toxicity of antiretroviral treatment regimens and implications for an aging population","volume":"7","author":"Chawla","year":"2018","journal-title":"Infect. Dis. Ther."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120986","article-title":"Dual loaded nanostructured lipid carrier of nano-selenium and Etravirine as a potential anti-HIV therapy","volume":"607","author":"Rojekar","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.105916","article-title":"Multi-organ targeting of HIV-1 viral reservoirs with etravirine loaded nanostructured lipid carrier: an in-vivo proof of concept","volume":"164","author":"Rojekar","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0050","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2313823121","article-title":"Monocyte to macrophage differentiation and changes in cellular redox homeostasis promote cell type-specific HIV latency reactivation","volume":"121","author":"Blanco","year":"2024","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0055","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3390\/biomedicines11020617","article-title":"HIV latency and nanomedicine strategies for anti-HIV treatment and eradication","volume":"11","author":"Andre","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0060","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12951-022-01750-w","article-title":"Tenofovir-tethered gold nanoparticles as a novel multifunctional long-acting anti-HIV therapy to overcome deficient drug delivery-: an in vivo proof of concept","volume":"21","author":"Fotooh Abadi","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0065","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.776","article-title":"Nanoparticle delivery system, highly active antiretroviral therapy, and testicular morphology: the role of stereology","volume":"9","author":"Naidu","year":"2021","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0070","first-page":"418","article-title":"Efavirenz loaded nanostructured lipid carriers for efficient and prolonged viral inhibition in HIV-infected macrophages","volume":"27","author":"Mahajan","year":"2020","journal-title":"Pharmaceut. Sci."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-021-01981-4","article-title":"Layer-by-layer assembled nanostructured lipid carriers for CD-44 receptor\u2013based targeting in HIV-infected macrophages for efficient HIV-1 inhibition","volume":"22","author":"Mahajan","year":"2021","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0080","doi-asserted-by":"crossref","first-page":"9009","DOI":"10.7150\/thno.59728","article-title":"CD4+ T cell-mimicking nanoparticles encapsulating DIABLO\/SMAC mimetics broadly neutralize HIV-1 and selectively kill HIV-1-infected cells","volume":"11","author":"Campbell","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00789","article-title":"Nanoparticle-based immunoengineered approaches for combating HIV","volume":"11","author":"Bowen","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0090","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejpb.2018.06.002","article-title":"Nanotechnology approaches to eradicating HIV reservoirs","volume":"138","author":"Cao","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0095","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3390\/pharmaceutics16030407","article-title":"Nanomedicine for the treatment of viral diseases: smaller solution to bigger problems","volume":"16","author":"Ghorai","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.765034","article-title":"The mannose receptor: from endocytic receptor and biomarker to regulator of (Meta)inflammation","volume":"12","author":"van der Zande","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0105","series-title":"Mannose Receptor","first-page":"221","author":"Pontow","year":"1993"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0110","doi-asserted-by":"crossref","first-page":"10649","DOI":"10.1073\/pnas.1605885113","article-title":"Mannose receptor induces T-cell tolerance via inhibition of CD45 and up-regulation of CTLA-4","volume":"113","author":"Schuette","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0115","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.4049\/jimmunol.146.8.2783","article-title":"Mechanisms of host defense against Candida species. I. Phagocytosis by monocytes and monocyte-derived macrophages","volume":"146","author":"Mar\u00f3di","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0120","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1645\/0022-3395(2001)087[1023:MOMMRA]2.0.CO;2","article-title":"Modulation of macrophage mannose receptor affects the uptake of virulent and avirulent Leishmania donovani promastigotes","volume":"87","author":"Chakraborty","year":"2001","journal-title":"J. Parasitol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0125","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/immu.200310024","article-title":"Involvement of macrophage mannose receptor in the binding and transmission of HIV by macrophages","volume":"33","author":"Nguyen","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0130","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1084\/jem.182.2.389","article-title":"Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products","volume":"182","author":"Sallusto","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0135","doi-asserted-by":"crossref","first-page":"12111","DOI":"10.1074\/jbc.RA120.013100","article-title":"The barley lectin, horcolin, binds high-mannose glycans in a multivalent fashion, enabling high-affinity, specific inhibition of cellular HIV infection","volume":"295","author":"Jayaprakash","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0140","series-title":"THE GLOBAL HEALTH OBSERVATORY: Explore a World of Health Data","author":"World Health Organization","year":"2023"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0145","series-title":"Key Facts HIV","author":"World Health Organization","year":"2022"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0150","series-title":"Health Topics\/HIV","author":"World Health Organization","year":"2023"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0155","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000445852","article-title":"Human immunodeficiency virus (HIV)","volume":"43","year":"2016","journal-title":"Transfus. Med. Hemother."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0160","series-title":"HIV and AIDS","author":"World Health Organization","year":"2023"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0165","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3390\/v14010152","article-title":"HIV-1 and HTLV-1 transmission modes: mechanisms and importance for virus spread","volume":"14","author":"Kalinichenko","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0170","series-title":"HIV Overview","author":"National Institute of Health","year":"2023"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0175","series-title":"How Can You Tell If You Have HIV?","author":"National Institute of Health","year":"2023"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0180","series-title":"The Stages of HIV Infection","author":"National Institute of Health","year":"2023"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0185","series-title":"Symptoms of HIV","author":"National Institute of Health","year":"2023"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0190","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.55806","article-title":"HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137","volume":"9","author":"Zhang","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0195","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s12192-021-01223-3","article-title":"Diversity in heat shock protein families: functional implications in virus infection with a comprehensive insight of their role in the HIV-1 life cycle","volume":"26","author":"Iyer","year":"2021","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0200","series-title":"Viral Replication Cycle - from Pathogenesis and Immune Response to Diagnosis and Therapy","article-title":"Exploring the replication mechanisms of DNA and RNA viruses","author":"Soltani","year":"2023"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0205","series-title":"Molecular Virology of Human Pathogenic Viruses","first-page":"31","article-title":"Virus life cycle","author":"Ryu","year":"2017"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0210","author":"Stanfordhealthcare"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0215","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev-med-041217-013717","article-title":"Long-acting HIV drugs for treatment and prevention","volume":"70","author":"Gulick","year":"2019","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0220","series-title":"HIV Treatment Overview","author":"HIV GOV","year":"2023"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0225","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev-med-041217-013717","article-title":"Long-acting HIV drugs for treatment and prevention","volume":"70","author":"Gulick","year":"2019","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0230","series-title":"ORGANISATION","author":"NATIONAL AIDS CONTROL","year":"2023"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0235","series-title":"FDA-Approved HIV Medicines","author":"National Institute of Health","year":"2023"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0240","doi-asserted-by":"crossref","first-page":"609","DOI":"10.20452\/pamw.4357","article-title":"Current challenges in the treatment of HIV","volume":"128","author":"Seyler","year":"2018","journal-title":"Pol. Arch. Intern. Med."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0245","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.3390\/polym14153090","article-title":"Novel nanotechnology-based approaches for targeting HIV reservoirs","volume":"14","author":"Fotooh Abadi","year":"2022","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0250","first-page":"229","article-title":"Adverse effects of antiretroviral therapy for HIV infection","volume":"170","author":"Montessori","year":"2004","journal-title":"CMAJ"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0255","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev-med-041217-013717","article-title":"Long-acting HIV drugs for treatment and prevention","volume":"70","author":"Gulick","year":"2019","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0260","first-page":"71","article-title":"Nanotechnology: a magic bullet for HIV AIDS treatment, Artif cells Nanomed","volume":"43","author":"Kumar","year":"2015","journal-title":"Biotechnol"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0265","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2217\/nnm.10.1","article-title":"Emerging nanotechnology approaches for HIV\/AIDS treatment and prevention","volume":"5","author":"Mamo","year":"2010","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122570","article-title":"Nanocarriers based novel and effective drug delivery system","volume":"632","author":"Khizar","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0275","series-title":"A Handbook of Artificial Intelligence in Drug Delivery","first-page":"145","article-title":"Application of artificial intelligence driving nano-based drug delivery system","author":"Zohuri","year":"2023"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0280","article-title":"Impairing tumor metabolic plasticity via a stable metal-phenolic-based polymeric nanomedicine to suppress colorectal cancer","volume":"35","author":"Li","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0285","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.apsb.2021.05.003","article-title":"GSH-sensitive polymeric prodrug: synthesis and loading with photosensitizers as nanoscale chemo-photodynamic anti-cancer nanomedicine","volume":"12","author":"Luo","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0290","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jconrel.2014.08.003","article-title":"Targeting strategies for delivery of anti-HIV drugs","volume":"192","author":"Ramana","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0295","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.3390\/polym14153090","article-title":"Novel nanotechnology-based approaches for targeting HIV reservoirs","volume":"14","author":"Fotooh Abadi","year":"2022","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0300","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1021\/acs.jmedchem.3c01543","article-title":"Antiviral protein\u2013protein interaction inhibitors","volume":"67","author":"Markovi\u0107","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10719-023-10142-7","article-title":"Mannose-specific plant and microbial lectins as antiviral agents: a review","volume":"41","author":"Gupta","year":"2024","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0310","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/immu.200310024","article-title":"Involvement of macrophage mannose receptor in the binding and transmission of HIV by macrophages","volume":"33","author":"Nguyen","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0315","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.antiviral.2009.08.003","article-title":"Sustained and specific in vitro inhibition of HIV-1 replication by a protease inhibitor encapsulated in gp120-targeted liposomes","volume":"84","author":"Clayton","year":"2009","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0320","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1128\/AAC.00254-10","article-title":"Actinohivin, a broadly neutralizing prokaryotic lectin, inhibits HIV-1 infection by specifically targeting high-mannose-type Glycans on the gp120 envelope","volume":"54","author":"Hoorelbeke","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1985","key":"10.1016\/j.jconrel.2024.06.002_bb0325","first-page":"1402","article-title":"Characterization of gp41 as the transmembrane protein coded by the HTLV-III\/LAV envelope gene","volume":"229","author":"Veronese","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0330","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1089\/aid.1994.10.1651","article-title":"A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1","volume":"10","author":"Purtscher","year":"1994","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030427","article-title":"Targeted killing of virally infected cells by radiolabeled antibodies to viral proteins","volume":"3","author":"Dadachova","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0340","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jconrel.2014.08.003","article-title":"Targeting strategies for delivery of anti-HIV drugs","volume":"192","author":"Ramana","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0345","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023202","article-title":"HIV envelope gp120 activates LFA-1 on CD4 T-lymphocytes and increases cell susceptibility to LFA-1-targeting Leukotoxin (LtxA)","volume":"6","author":"Hioe","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0350","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/mt.2009.271","article-title":"RNAi-mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT mice","volume":"18","author":"Kim","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0355","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1182\/blood-2007-05-088435","article-title":"HIV-1\u2013induced activation of CD4+ T cells creates new targets for HIV-1 infection in human lymphoid tissue ex vivo","volume":"111","author":"Biancotto","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0360","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jconrel.2014.08.003","article-title":"Targeting strategies for delivery of anti-HIV drugs","volume":"192","author":"Ramana","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0365","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2217\/17435889.4.1.105","article-title":"Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders","volume":"4","author":"Muthu","year":"2009","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0370","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.virol.2014.04.016","article-title":"DC-SIGN plays a stronger role than DCIR in mediating HIV-1 capture and transfer","volume":"458\u2013459","author":"Jin","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0375","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jconrel.2014.08.003","article-title":"Targeting strategies for delivery of anti-HIV drugs","volume":"192","author":"Ramana","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0380","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/0958-1669(91)90089-N","article-title":"CD4: its structure, role in immune function and AIDS pathogenesis, and potential as a pharmacological target","volume":"2","author":"Sweet","year":"1991","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0385","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1006\/bbrc.1996.1592","article-title":"Targeting of liposomes to HIV-1-infected cells by peptides derived from the CD4 receptor","volume":"227","author":"Slepushkin","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0390","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/QAI.0b013e3182653c1f","article-title":"Enhanced anti-HIV efficacy of Indinavir after inclusion in CD4-targeted lipid nanoparticles","volume":"61","author":"Endsley","year":"2012","journal-title":"JAIDS J. Acquired Immune Deficiency Syndrom."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0395","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3201\/eid0303.970302","article-title":"Host genes and HIV: the role of the chemokine receptor gene CCR5 and its allele (32 CCR5)","volume":"3","author":"McNicholl","year":"1997","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0400","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1128\/JVI.75.2.579-588.2001","article-title":"Potent, broad-Spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140","volume":"75","author":"Trkola","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0405","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.molimm.2004.06.015","article-title":"Mannose binding lectin (MBL) and HIV","volume":"42","author":"Ji","year":"2005","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0410","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/jac\/dkt414","article-title":"Exposure of HIV-1 to a combination of two carbohydrate-binding agents markedly delays drug resistance development and selects for virus strains with compromised fitness","volume":"69","author":"Mathys","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0415","doi-asserted-by":"crossref","first-page":"9345","DOI":"10.1074\/jbc.M411122200","article-title":"Isolation and characterization of Griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp","volume":"280","author":"Mori","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0420","doi-asserted-by":"crossref","first-page":"24066","DOI":"10.1074\/jbc.274.34.24066","article-title":"Transferrin Trojan horses as a rational approach for the biological delivery of therapeutic peptide domains","volume":"274","author":"Ali","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0425","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2217\/nnm.11.25","article-title":"Targeting nevirapine delivery across human brain microvascular endothelial cells using transferrin-grafted poly(lactide- co -glycolide) nanoparticles","volume":"6","author":"Kuo","year":"2011","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0430","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.3390\/molecules28093838","article-title":"Screening and identification of ssDNA aptamers for low-density lipoprotein (LDL) receptor-related protein 6","volume":"28","author":"Zhang","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0435","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jconrel.2014.08.003","article-title":"Targeting strategies for delivery of anti-HIV drugs","volume":"192","author":"Ramana","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0440","article-title":"Pharmaceutical approaches to HIV treatment and prevention","volume":"1","author":"Yavuz","year":"2018","journal-title":"Adv. Ther. (Weinh)"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0445","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1016\/j.ddtec.2011.11.010","article-title":"Enhanced permeability and retention effect for selective targeting of anticancer nanomedicine: are we there yet?","volume":"9","author":"Greish","year":"2012","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0450","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1089\/aid.1996.12.1709","article-title":"Macrophage targeting of azidothymidine: a promising strategy for AIDS therapy*","volume":"12","author":"L\u00f6benberg","year":"1996","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0455","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.virol.2006.08.012","article-title":"Laboratory investigations for the morphologic, pharmacokinetic, and anti-retroviral properties of indinavir nanoparticles in human monocyte-derived macrophages","volume":"358","author":"Dou","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0460","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jconrel.2014.08.003","article-title":"Targeting strategies for delivery of anti-HIV drugs","volume":"192","author":"Ramana","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0465","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1749-6632.2001.tb03909.x","article-title":"HIV Inhibitors: problems and reality","volume":"946","author":"T\u00f6zs\u00e9r","year":"2001","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0470","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1074\/jbc.275.3.1993","article-title":"A Urokinase receptor-associated protein with specific collagen binding properties","volume":"275","author":"Behrendt","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0475","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1242\/jcs.113.6.1021","article-title":"Endo180, an endocytic recycling glycoprotein related to the macrophage mannose receptor is expressed on fibroblasts, endothelial cells and macrophages and functions as a lectin receptor","volume":"113","author":"Sheikh","year":"2000","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0480","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/375151a0","article-title":"The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing","volume":"375","author":"Jiang","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0485","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/infdis\/jiy318","article-title":"Soluble macrophage mannose receptor (sCD206\/sMR) as a biomarker in human immunodeficiency virus infection","volume":"218","author":"Andersen","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0490","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.celrep.2017.12.085","article-title":"Mannose receptor 1 restricts HIV particle release from infected macrophages","volume":"22","author":"Sukegawa","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0495","first-page":"197","article-title":"Mannose-decorated hybrid nanoparticles for enhanced macrophage targeting","volume":"17","author":"Hatami","year":"2019","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0500","doi-asserted-by":"crossref","DOI":"10.1111\/boc.202200085","article-title":"Get in and get out: remodeling of the cellular actin cytoskeleton upon HIV-1 infection","volume":"115","author":"Serrano","year":"2023","journal-title":"Biol. Cell."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0505","doi-asserted-by":"crossref","first-page":"9506","DOI":"10.1128\/JVI.00650-11","article-title":"The HIV-1 tat protein has a versatile role in activating viral transcription","volume":"85","author":"Das","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0510","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3390\/microorganisms12030425","article-title":"The role of HIV-1-encoded microRNAs in viral replication","volume":"12","author":"Carmi","year":"2024","journal-title":"Microorganisms"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0515","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.3390\/ijms25031704","article-title":"Role of HIV-1 tat protein interactions with host receptors in HIV infection and pathogenesis","volume":"25","author":"Cafaro","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0520","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3390\/microorganisms12030425","article-title":"The role of HIV-1-encoded microRNAs in viral replication","volume":"12","author":"Carmi","year":"2024","journal-title":"Microorganisms"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0525","doi-asserted-by":"crossref","first-page":"29","DOI":"10.59566\/IJBS.2008.4029","article-title":"Different effects of regulatory genes (tat, nef) of human immunodeficiency virus type 1 (HIV-1) on the proliferation and differentiation of mouse embryonic stem cells in vitro","volume":"4","author":"Manuilova","year":"2008","journal-title":"Int. J. Biomed. Sci."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2024.109947","article-title":"Cellular HSF1 expression is induced during HIV-1 infection by activation of its promoter mediated through the cooperative interaction of HSF1 and viral Nef protein","volume":"754","author":"Mitra","year":"2024","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0535","doi-asserted-by":"crossref","DOI":"10.1093\/jmcb\/mjae005","article-title":"Antiviral factors and their counteraction by HIV-1: many uncovered and more to be discovered","author":"Kmiec","year":"2024","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0540","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3390\/v16040500","article-title":"Friends and foes: the ambivalent role of autophagy in HIV-1 infection","volume":"16","author":"Klute","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0545","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3390\/v16020254","article-title":"Role of viral envelope proteins in determining susceptibility of viruses to IFITM proteins","volume":"16","author":"Marceau","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0550","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1189\/jlb.0804454","article-title":"HIV-1 Nef mediates post-translational down-regulation and redistribution of the mannose receptor","volume":"77","author":"Vigerust","year":"2005","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.crneur.2023.100108","article-title":"Astrocytes: role in pathogenesis and effect of commonly misused drugs in the HIV infected brain","volume":"5","author":"Pla-Tenorio","year":"2023","journal-title":"Curr. Res. Neurobiol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0560","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12439","article-title":"Neuropathogenic role of astrocyte-derived extracellular vesicles in HIV-associated neurocognitive disorders","volume":"13","author":"Chemparathy","year":"2024","journal-title":"J. Extracell Vesicles"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0565","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbadis.2004.12.001","article-title":"HIV-1 interaction with human mannose receptor (hMR) induces production of matrix metalloproteinase 2 (MMP-2) through hMR-mediated intracellular signaling in astrocytes","volume":"1741","author":"L\u00f3pez-Herrera","year":"2005","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0570","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.3390\/ijms25031370","article-title":"Mannose ligands for mannose receptor targeting","volume":"25","author":"Paurevi\u0107","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0575","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.3390\/biomedicines11102769","article-title":"Biomimetic system based on reconstituted macrophage membranes for analyzing and selection of higher-affinity ligands specific to mannose receptor to develop the macrophage-focused medicines","volume":"11","author":"Zlotnikov","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0580","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbadis.2004.12.001","article-title":"HIV-1 interaction with human mannose receptor (hMR) induces production of matrix metalloproteinase 2 (MMP-2) through hMR-mediated intracellular signaling in astrocytes","volume":"1741","author":"L\u00f3pez-Herrera","year":"2005","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0585","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.celrep.2017.12.085","article-title":"Mannose receptor 1 restricts HIV particle release from infected macrophages","volume":"22","author":"Sukegawa","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0590","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02686-23","article-title":"Alternative substitutions of N332 in HIV-1 AD8 gp120 differentially affect envelope glycoprotein function and viral sensitivity to broadly neutralizing antibodies targeting the V3-glycan","volume":"15","author":"Jeffy","year":"2024","journal-title":"MBio"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0595","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00592-23","article-title":"Alterations in gp120 glycans or the gp41 fusion peptide-proximal region modulate the stability of the human immunodeficiency virus (HIV-1) envelope glycoprotein pretriggered conformation","volume":"97","author":"Zhang","year":"2023","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0600","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/immu.200310024","article-title":"Involvement of macrophage mannose receptor in the binding and transmission of HIV by macrophages","volume":"33","author":"Nguyen","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0605","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3390\/v16030420","article-title":"HIV-1 Vpr functions in primary CD4+ T cells","volume":"16","author":"Vanegas-Torres","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0610","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.51035","article-title":"Mannose receptor is an HIV restriction factor counteracted by Vpr in macrophages","volume":"9","author":"Lubow","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0615","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12985-024-02363-5","article-title":"Vpr driving DNA methylation variation of CD4+T cells in HIV-1 infection","volume":"21","author":"Wang","year":"2024","journal-title":"Virol. J."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0620","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1084\/jem.191.7.1105","article-title":"Crystal structure of the cysteine-rich domain of mannose receptor complexed with a sulfated carbohydrate ligand","volume":"191","author":"Liu","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0625","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/S0021-9258(18)46005-X","article-title":"Contribution to ligand binding by multiple carbohydrate-recognition domains in the macrophage mannose receptor","volume":"267","author":"Taylor","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0630","doi-asserted-by":"crossref","first-page":"21539","DOI":"10.1074\/jbc.M002366200","article-title":"Structure of a C-type carbohydrate recognition domain from the macrophage mannose receptor","volume":"275","author":"Feinberg","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0635","doi-asserted-by":"crossref","first-page":"5668","DOI":"10.1074\/jbc.272.9.5668","article-title":"Mechanism of Ca2- and monosaccharide binding to a C-type carbohydrate-recognition domain of the macrophage mannose receptor","volume":"272","author":"Mullin","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0640","doi-asserted-by":"crossref","first-page":"29694","DOI":"10.1074\/jbc.M000571200","article-title":"A Di-aromatic motif in the cytosolic tail of the mannose receptor mediates endosomal sorting","volume":"275","author":"Schweizer","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0645","doi-asserted-by":"crossref","first-page":"12156","DOI":"10.1016\/S0021-9258(19)38325-5","article-title":"Primary structure of the mannose receptor contains multiple motifs resembling carbohydrate-recognition domains","volume":"265","author":"Taylor","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0650","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/(SICI)1098-1136(19990101)25:1<44::AID-GLIA5>3.0.CO;2-C","article-title":"Identification and functional characterization of the mannose receptor in astrocytes","volume":"25","author":"Burudi","year":"1999","journal-title":"Glia"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0655","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.1128\/JVI.74.11.5190-5197.2000","article-title":"Involvement of the mannose receptor in infection of macrophages by influenza virus","volume":"74","author":"Reading","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0660","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/10611860009009207","article-title":"Pharmacokinetics and in vivo gene transfer of plasmid DNA complexed with mannosylated poly(L-lysine) in mice","volume":"8","author":"Nishikawa","year":"2000","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0665","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1093\/intimm\/11.11.1775","article-title":"Human dendritic cells shed a functional, soluble form of the mannose receptor","volume":"11","author":"Jordens","year":"1999","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0670","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3109\/10611869909085522","article-title":"Synthesis, characterisation and in vivo behaviour of a norfloxacin-poly(L-lysine citramide imide) conjugate bearing mannosyl residues","volume":"7","author":"Gac","year":"2000","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0675","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/10611860009009207","article-title":"Pharmacokinetics and in vivo gene transfer of plasmid DNA complexed with Mannosylated poly(L-lysine) in mice","volume":"8","author":"Nishikawa","year":"2000","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0680","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.coi.2005.05.011","article-title":"Levels of complexity in pathogen recognition by C-type lectins","volume":"17","author":"Cambi","year":"2005","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0685","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.4049\/jimmunol.172.5.2845","article-title":"Mannose receptor targeting of tumor antigen pmel17 to human dendritic cells directs anti-melanoma T cell responses via multiple HLA molecules","volume":"172","author":"Ramakrishna","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0690","doi-asserted-by":"crossref","first-page":"6259","DOI":"10.4049\/jimmunol.178.10.6259","article-title":"Antigenic targeting of the human mannose receptor induces tumor immunity","volume":"178","author":"He","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0695","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1182\/blood-2005-03-1252","article-title":"DC-SIGN ligation on dendritic cells results in ERK and PI3K activation and modulates cytokine production","volume":"107","author":"Caparr\u00f3s","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0700","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/ni1470","article-title":"Activation of the lectin DC-SIGN induces an immature dendritic cell phenotype triggering rho-GTPase activity required for HIV-1 replication","volume":"8","author":"Hodges","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0705","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1462-5822.2005.00623.x","article-title":"Neisseria meningitidis expressing lgtB lipopolysaccharide targets DC-SIGN and modulates dendritic cell function","volume":"8","author":"Steeghs","year":"2006","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0710","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.molimm.2004.06.013","article-title":"Divergent roles for C-type lectins expressed by cells of the innate immune system","volume":"41","author":"Mcgreal","year":"2004","journal-title":"Mol. Immunol."},{"issue":"2002","key":"10.1016\/j.jconrel.2024.06.002_bb0715","first-page":"1898","article-title":"Mannose receptor-mediated regulation of serum glycoprotein homeostasis","volume":"295","author":"Lee","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0720","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/eji.200535685","article-title":"Carbohydrate-independent recognition of collagens by the macrophage mannose receptor","volume":"36","author":"Martinez-Pomares","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0725","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0092-8674(00)80693-5","article-title":"Identification of DC-SIGN, a novel dendritic cell\u2013specific ICAM-3 receptor that supports primary immune responses","volume":"100","author":"Geijtenbeek","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0730","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1096\/fj.03-0110com","article-title":"Macrophage migration inhibitory factor delays apoptosis in neutrophils by inhibiting the mitochondria-dependent death pathway","volume":"17","author":"Baumann","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0735","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.4049\/jimmunol.178.8.4975","article-title":"Mannose receptor expression and function define a new population of murine dendritic cells","volume":"178","author":"McKenzie","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0740","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/ejh.14171","article-title":"Soluble mannose receptor: a potential biomarker in Gaucher disease","volume":"112","author":"Beaton","year":"2024","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0745","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2103304118","article-title":"Soluble mannose receptor induces proinflammatory macrophage activation and metaflammation","volume":"118","author":"Embgenbroich","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0750","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1111\/liv.14466","article-title":"Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitis","volume":"40","author":"Bossen","year":"2020","journal-title":"Liver Int."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0755","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2022.102394","article-title":"The mannose receptor ligands and the macrophage glycome","volume":"75","author":"Cummings","year":"2022","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0760","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.3390\/metabo12121205","article-title":"Mannose receptor deficiency impacts Bone marrow and circulating immune cells during high fat diet induced obesity","volume":"12","author":"Nour","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0765","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.765034","article-title":"The mannose receptor: from endocytic receptor and biomarker to regulator of (Meta)inflammation","volume":"12","author":"van der Zande","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0770","doi-asserted-by":"crossref","first-page":"19616","DOI":"10.1038\/s41598-021-98611-7","article-title":"The mannose receptor (CD206) identifies a population of colonic macrophages in health and inflammatory bowel disease","volume":"11","author":"Wright","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0775","article-title":"Macrophage activation markers, soluble CD163 and mannose receptor, in liver fibrosis","volume":"7","author":"Gantzel","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0780","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax6337","article-title":"Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses","volume":"12","author":"Jaynes","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0785","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.it.2004.12.001","article-title":"The mannose receptor: linking homeostasis and immunity through sugar recognition","volume":"26","author":"Taylor","year":"2005","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0790","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01068","article-title":"L-selectin: a major regulator of leukocyte adhesion, migration and signaling","volume":"10","author":"Ivetic","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0795","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.00309","article-title":"C-type lectin receptors in host defense against bacterial pathogens","volume":"10","author":"Mnich","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0800","doi-asserted-by":"crossref","DOI":"10.1016\/j.dci.2021.104257","article-title":"Expression and functional characterization of the mannose receptor (MR) from Nile tilapia (Oreochromis niloticus) in response to bacterial infection","volume":"126","author":"Yin","year":"2022","journal-title":"Dev. Comp. Immunol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0805","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012695","article-title":"Mannose receptor-derived peptides neutralize pore-forming toxins and reduce inflammation and development of pneumococcal disease","volume":"12","author":"Subramanian","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0810","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12987-023-00409-4","article-title":"Effects of bacterial and viral pathogen-associated molecular patterns (PAMPs) on multidrug resistance (MDR) transporters in brain endothelial cells of the developing human blood\u2013brain barrier","volume":"20","author":"Lye","year":"2023","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0815","doi-asserted-by":"crossref","DOI":"10.1161\/ATVBAHA.120.314330","article-title":"Vascular endothelial cells and innate immunity","volume":"40","author":"Shao","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0820","first-page":"165845","article-title":"Mitochondrial function in immune cells in health and disease","volume":"2020","author":"Faas","year":"1866","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0825","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/9914854","article-title":"Toll-like receptors: general molecular and structural biology","volume":"2021","author":"Behzadi","year":"2021","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0830","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.immuni.2024.03.005","article-title":"Myeloid C-type lectin receptors in innate immune recognition","volume":"57","author":"Sousa","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0835","first-page":"5790","article-title":"From structure to function \u2013 ligand recognition by myeloid C-type lectin receptors, Comput Struct","volume":"20","author":"Fischer","year":"2022","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0840","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.it.2019.11.007","article-title":"T cell antifungal immunity and the role of C-type lectin receptors","volume":"41","author":"Speakman","year":"2020","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0845","series-title":"Mannose Receptor and Targeting Strategies","first-page":"433","author":"Jahagirdar","year":"2019"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0850","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1126043","article-title":"The diverse roles of C-type lectin-like receptors in immunity","volume":"14","author":"Scur","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0855","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0213-9626(08)70061-1","article-title":"The homeostatic properties of the mannose receptor in health and disease","volume":"27","author":"Martinez-Pomares","year":"2008","journal-title":"Inmunolog\u00eda"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0860","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0304-4165(02)00319-7","article-title":"The mannose receptor family","volume":"1572","author":"East","year":"2002","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0865","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1042\/BJ20052027","article-title":"Collagen binding by the mannose receptor mediated through the fibronectin type II domain","volume":"395","author":"Napper","year":"2006","journal-title":"Biochem. J."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0870","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1615\/CritRevImmunol.v24.i3.20","article-title":"From pattern recognition receptor to regulator of homeostasis: the double-faced macrophage mannose receptor","volume":"24","author":"Allavena","year":"2004","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0875","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1189\/jlb.0512231","article-title":"The mannose receptor","volume":"92","author":"Martinez-Pomares","year":"2012","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0880","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1128\/IAI.67.2.469-477.1999","article-title":"The mannose receptor mediates uptake of pathogenic and nonpathogenic mycobacteria and bypasses bactericidal responses in human macrophages","volume":"67","author":"Astarie-Dequeker","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0885","doi-asserted-by":"crossref","first-page":"691","DOI":"10.4049\/jimmunol.1500710","article-title":"Mannose-capped lipoarabinomannan from mycobacterium tuberculosis induces CD4+ T cell anergy via GRAIL","volume":"196","author":"Sande","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0890","series-title":"Structure and Function of the Macrophage Mannose Receptor","first-page":"105","author":"Taylor","year":"2001"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0895","doi-asserted-by":"crossref","first-page":"4676","DOI":"10.4049\/jimmunol.1101876","article-title":"HIV-1 N -glycan composition governs a balance between dendritic cell-mediated viral transmission and antigen presentation","volume":"187","author":"van Montfort","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0900","doi-asserted-by":"crossref","first-page":"a006866","DOI":"10.1101\/cshperspect.a006866","article-title":"HIV: cell binding and entry","volume":"2","author":"Wilen","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0905","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1615\/CritRevImmunol.v24.i3.20","article-title":"From pattern recognition receptor to regulator of homeostasis: the double-faced macrophage mannose receptor","volume":"24","author":"Allavena","year":"2004","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0910","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1084\/jem.191.7.1117","article-title":"The cysteine-rich domain of the macrophage mannose receptor is a multispecific lectin that recognizes chondroitin sulfates a and B and sulfated oligosaccharides of blood group lewisa and Lewisx types in addition to the sulfated N -glycans of lutropin","volume":"191","author":"Leteux","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0915","doi-asserted-by":"crossref","first-page":"35211","DOI":"10.1074\/jbc.274.49.35211","article-title":"Cell-specific Glycoforms of Sialoadhesin and CD45 are counter-receptors for the cysteine-rich domain of the mannose receptor","volume":"274","author":"Mart\u00ednez-Pomares","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0920","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3390\/biom11020188","article-title":"Human lectins, their carbohydrate affinities and where to find them","volume":"11","author":"Raposo","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0925","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1084\/jem.191.7.1117","article-title":"The cysteine-rich domain of the macrophage mannose receptor is a multispecific lectin that recognizes chondroitin sulfates a and B and sulfated oligosaccharides of blood group lewisa and lewisx types in addition to the sulfated N -Glycans of lutropin","volume":"191","author":"Leteux","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0930","doi-asserted-by":"crossref","first-page":"32811","DOI":"10.1074\/jbc.M503457200","article-title":"Glycosylation influences the lectin activities of the macrophage mannose receptor","volume":"280","author":"Su","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0935","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.1016\/j.csbj.2022.10.019","article-title":"From structure to function \u2013 ligand recognition by myeloid C-type lectin receptors","volume":"20","author":"Fischer","year":"2022","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0940","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100368","article-title":"Structural analysis of carbohydrate binding by the macrophage mannose receptor CD206","volume":"296","author":"Feinberg","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0945","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1172\/JCI41560","article-title":"Mannose receptor interacts with Fc receptors and is critical for the development of crescentic glomerulonephritis in mice","volume":"120","author":"Chavele","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0950","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1111\/brv.12316","article-title":"Mannoside recognition and degradation by bacteria","volume":"92","author":"Ladev\u00e8ze","year":"2017","journal-title":"Biol. Rev."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0955","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s11051-022-05594-1","article-title":"Applications of mannose-binding lectins and mannan glycoconjugates in nanomedicine","volume":"24","author":"Gupta","year":"2022","journal-title":"J. Nanopart. Res."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0960","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3390\/pathogens9090694","article-title":"Glycoprotein- and lectin-based approaches for detection of pathogens","volume":"9","author":"Hassan","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0965","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3390\/biom11020188","article-title":"Human lectins, their carbohydrate affinities and where to find them","volume":"11","author":"Raposo","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0970","series-title":"C-Type Lectin Receptors in Immunity, Springer Japan, Tokyo","first-page":"191","article-title":"The ligands of C-type lectins","author":"Foster","year":"2016"},{"key":"10.1016\/j.jconrel.2024.06.002_bb0975","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/jcb.240450204","article-title":"Lectin cell adhesion molecules (LEC-CAMs): a new family of cell adhesion proteins involved with inflammation","volume":"45","author":"Lasky","year":"1991","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0980","doi-asserted-by":"crossref","first-page":"15829","DOI":"10.1073\/pnas.0707426104","article-title":"Polylactosamine on glycoproteins influences basal levels of lymphocyte and macrophage activation","volume":"104","author":"Togayachi","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0985","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1039\/C9MO00173E","article-title":"Mycobacterium bovis BCG infection alters the macrophage N -glycome","volume":"16","author":"Delannoy","year":"2020","journal-title":"Mol. Omics."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0990","doi-asserted-by":"crossref","first-page":"E14","DOI":"10.1111\/j.1749-6632.2012.06698.x","article-title":"Diversity in recognition of glycans by F-type lectins and galectins: molecular, structural, and biophysical aspects","volume":"1253","author":"Vasta","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jconrel.2024.06.002_bb0995","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3390\/pharmaceutics12030243","article-title":"A novel bivalent mannosylated targeting ligand displayed on nanoparticles selectively targets anti-inflammatory M2 macrophages","volume":"12","author":"Chen","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1000","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.3390\/ph15101172","article-title":"Mannosylated polymeric ligands for targeted delivery of antibacterials and their adjuvants to macrophages for the enhancement of the drug efficiency","volume":"15","author":"Zlotnikov","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1005","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1039\/D0TB00049C","article-title":"Dual-self-recognizing, stimulus-responsive and carrier-free methotrexate\u2013mannose conjugate nanoparticles with highly synergistic chemotherapeutic effects","volume":"8","author":"Fan","year":"2020","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1010","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bmt.2023.09.001","article-title":"Review of the efficacy of nanoparticle-based drug delivery systems for cancer treatment","volume":"5","author":"Elumalai","year":"2024","journal-title":"Biomed. Tech."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1015","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.nano.2011.03.005","article-title":"Experimental and theoretical comparison of intracellular import of polymeric nanoparticles and small molecules: toward models of uptake kinetics","volume":"7","author":"Salvati","year":"2011","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1020","doi-asserted-by":"crossref","first-page":"16014","DOI":"10.1038\/natrevmats.2016.14","article-title":"Analysis of nanoparticle delivery to tumours","volume":"1","author":"Wilhelm","year":"2016","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1025","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1519","article-title":"Strategies to improve tumor penetration of nanomedicines through nanoparticle design","volume":"11","author":"Zhang","year":"2019","journal-title":"WIREs Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1030","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114708","article-title":"Nanoparticle biodistribution coefficients: a quantitative approach for understanding the tissue distribution of nanoparticles","volume":"194","author":"Kumar","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1035","series-title":"Drug Delivery with Targeted Nanoparticles","author":"\u00c7apan","year":"2021"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1040","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijbiomac.2017.12.143","article-title":"Mannose-conjugated curcumin-chitosan nanoparticles: efficacy and toxicity assessments against Leishmania donovani","volume":"111","author":"Chaubey","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1045","first-page":"197","article-title":"Mannose-decorated hybrid nanoparticles for enhanced macrophage targeting","volume":"17","author":"Hatami","year":"2019","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1050","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1021\/bc200663r","article-title":"Cellular uptake of gold nanoparticles bearing HIV gp120 Oligomannosides","volume":"23","author":"Arn\u00e1iz","year":"2012","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1055","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.carres.2014.07.012","article-title":"Assembling different antennas of the gp120 high mannose-type glycans on gold nanoparticles provides superior binding to the anti-HIV antibody 2G12 than the individual antennas","volume":"405","author":"Chiodo","year":"2015","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1060","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1021\/acs.molpharmaceut.7b00555","article-title":"Layer-by-layer engineered microbicide drug delivery system targeting HIV-1 gp120: physicochemical and biological properties","volume":"14","author":"Coulibaly","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1065","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/10611860600965914","article-title":"Poly (propyleneimine) dendrimer based nanocontainers for targeting of efavirenz to human monocytes\/macrophages in vitro","volume":"15","author":"Dutta","year":"2007","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1070","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ejps.2012.12.027","article-title":"Synthesis, characterization and targeting potential of zidovudine loaded sialic acid conjugated-mannosylated poly(propyleneimine) dendrimers","volume":"48","author":"Gajbhiye","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1075","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.1002\/anie.201600593","article-title":"Compact, polyvalent mannose quantum dots as sensitive, ratiometric FRET probes for multivalent protein-ligand interactions","volume":"55","author":"Guo","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1080","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nano.2007.11.004","article-title":"Mannosylated gelatin nanoparticles bearing an anti-HIV drug didanosine for site-specific delivery","volume":"4","author":"Jain","year":"2008","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1085","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/21691401.2017.1414054","article-title":"Efaverinz and nano-gold-loaded mannosylated niosomes: a host cell-targeted topical HIV-1 prophylaxis via thermogel system","volume":"46","author":"Malik","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1090","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1208\/s12249-022-02377-8","article-title":"Mannose-anchored nano-selenium loaded nanostructured lipid carriers of etravirine for delivery to HIV reservoirs","volume":"23","author":"Rojekar","year":"2022","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1095","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2174\/157341310791658928","article-title":"Receptor specific macrophage targeting by mannose-conjugated gelatin nanoparticles- an in vitro and in vivo study","volume":"6","author":"Mahajan","year":"2010","journal-title":"Curr. Nanosci."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1100","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2147\/IJN.S124692","article-title":"Targeted delivery of mannosylated-PLGA nanoparticles of antiretroviral drug to brain","volume":"13","author":"Patel","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1105","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/026520400288427","article-title":"Gelatin nanoparticles by two step desolvation a new preparation method, surface modifications and cell uptake","volume":"17","author":"Coester","year":"2000","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1110","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/21691401.2017.1414054","article-title":"Efaverinz and nano-gold-loaded mannosylated niosomes: a host cell-targeted topical HIV-1 prophylaxis via thermogel system","volume":"46","author":"Malik","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1115","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nano.2007.11.004","article-title":"Mannosylated gelatin nanoparticles bearing an anti-HIV drug didanosine for site-specific delivery","volume":"4","author":"Jain","year":"2008","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1120","article-title":"Mannan-coated gelatin nanoparticles for sustained and targeted delivery of didanosine: in vitro and in vivo evaluation","volume":"58","author":"Kaur","year":"2008","journal-title":"Acta Pharma."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1125","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.bbagen.2006.12.007","article-title":"Targeting potential and anti-HIV activity of lamivudine loaded mannosylated poly (propyleneimine) dendrimer","volume":"1770","author":"Dutta","year":"2007","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1130","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/10611860600965914","article-title":"Poly (propyleneimine) dendrimer based nanocontainers for targeting of efavirenz to human monocytes\/macrophages in vitro","volume":"15","author":"Dutta","year":"2007","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1135","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1080\/10611860802475688","article-title":"Lymphatic targeting of zidovudine using surface-engineered liposomes","volume":"16","author":"Kaur","year":"2008","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1140","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3109\/1061186X.2010.499460","article-title":"Surface structured liposomes for site specific delivery of an antiviral agent-indinavir","volume":"19","author":"Dubey","year":"2011","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1145","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1211\/jpp.58.5.0005","article-title":"Stavudine-loaded mannosylated liposomes: in-vitro anti-HIV-I activity, tissue distribution and pharmacokinetics","volume":"58","author":"Garg","year":"2010","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1150","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/21691401.2017.1414054","article-title":"Efaverinz and nano-gold-loaded mannosylated niosomes: a host cell-targeted topical HIV-1 prophylaxis via thermogel system","volume":"46","author":"Malik","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1155","first-page":"197","article-title":"Mannose-decorated hybrid nanoparticles for enhanced macrophage targeting","volume":"17","author":"Hatami","year":"2019","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1160","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.nano.2017.11.009","article-title":"Loading dendritic cells with gold nanoparticles (GNPs) bearing HIV-peptides and mannosides enhance HIV-specific T cell responses","volume":"14","author":"Climent","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1165","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3390\/pharmaceutics13020223","article-title":"Targeting Beclin1 as an adjunctive therapy against HIV using mannosylated polyethylenimine nanoparticles","volume":"13","author":"Rodriguez","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1170","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3109\/1061186X.2010.499463","article-title":"Active targeting of dendritic cells with mannan-decorated PLGA nanoparticles","volume":"19","author":"Ghotbi","year":"2011","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1175","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1080\/21691401.2019.1577888","article-title":"HBs antigen and mannose loading on the surface of iron oxide nanoparticles in order to immuno-targeting: fabrication, characterization, cellular and humoral immunoassay","volume":"47","author":"Rezaei","year":"2019","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1180","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ab.2004.12.001","article-title":"Carbohydrate analysis by a phenol\u2013sulfuric acid method in microplate format","volume":"339","author":"Masuko","year":"2005","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1185","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12951-014-0059-z","article-title":"Carbohydrate functionalization of silver nanoparticles modulates cytotoxicity and cellular uptake","volume":"12","author":"Kennedy","year":"2014","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1190","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1021\/bm0344710","article-title":"Synthesis, characterization, and bioavailability of mannosylated shell cross-linked nanoparticles","volume":"5","author":"Joralemon","year":"2004","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1195","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1021\/bm801492c","article-title":"Polyester nanoparticles presenting mannose residues: toward the development of new vaccine delivery systems combining biodegradability and targeting properties","volume":"10","author":"Rieger","year":"2009","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1200","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.vaccine.2003.11.008","article-title":"Interaction of dendritic cells with antigen-containing liposomes: effect of bilayer composition","volume":"22","author":"Foged","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1205","doi-asserted-by":"crossref","first-page":"B1","DOI":"10.1016\/S0264-410X(02)00514-5","article-title":"A role for liposomes in genetic vaccination","volume":"20","author":"Gregoriadis","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2016.01.054","article-title":"Enhanced non-inflammasome mediated immune responses by mannosylated zwitterionic-based cationic liposomes for HIV DNA vaccines","volume":"85","author":"Qiao","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1215","article-title":"The immunogenicity of p24 protein from HIV-1 virus is strongly supported and modulated by coupling with liposomes and mannan","volume":"121844","author":"Zachov\u00e1","year":"2024","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1220","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.3390\/pharmaceutics14112300","article-title":"Synthesis & evaluation of novel mannosylated neoglycolipids for liposomal delivery system applications","volume":"14","author":"Mousavifar","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1225","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nano.2007.11.004","article-title":"Mannosylated gelatin nanoparticles bearing an anti-HIV drug didanosine for site-specific delivery","volume":"4","author":"Jain","year":"2008","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1230","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2147\/IJN.S124692","article-title":"Targeted delivery of mannosylated-PLGA nanoparticles of antiretroviral drug to brain","volume":"13","author":"Patel","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1235","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3390\/pharmaceutics13020223","article-title":"Targeting Beclin1 as an adjunctive therapy against HIV using mannosylated polyethylenimine nanoparticles","volume":"13","author":"Rodriguez","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1240","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1208\/s12249-022-02377-8","article-title":"Mannose-anchored nano-selenium loaded nanostructured lipid carriers of etravirine for delivery to HIV reservoirs","volume":"23","author":"Rojekar","year":"2022","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1245","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1166\/asem.2014.1613","article-title":"Production of mannosylated solid lipid nanoparticles to deliver the anti-retroviral drugs: efavirenz and nevirapine","volume":"6","author":"de Sousa","year":"2014","journal-title":"Adv. Sci. Eng. Med."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012309","article-title":"Structure activity relationship of dendrimer microbicides with dual action antiviral activity","volume":"5","author":"Tyssen","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1255","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.2147\/IJN.S96352","article-title":"Antiviral mechanism of polyanionic carbosilane dendrimers against HIV-1","author":"Munoz-Fernandez","year":"2016","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1260","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ejps.2012.12.027","article-title":"Synthesis, characterization and targeting potential of zidovudine loaded sialic acid conjugated-mannosylated poly(propyleneimine) dendrimers","volume":"48","author":"Gajbhiye","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1265","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.bbagen.2006.12.007","article-title":"Targeting potential and anti-HIV activity of lamivudine loaded mannosylated poly (propyleneimine) dendrimer","volume":"1770","author":"Dutta","year":"2007","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1270","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3390\/v15030647","article-title":"Advances in antiviral delivery systems and chitosan-based polymeric and nanoparticulate antivirals and antiviral carriers","volume":"15","author":"\u017digrayov\u00e1","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1275","doi-asserted-by":"crossref","first-page":"33393","DOI":"10.1038\/srep33393","article-title":"Linear biocompatible glyco-polyamidoamines as dual action mode virus infection inhibitors with potential as broad-spectrum microbicides for sexually transmitted diseases","volume":"6","author":"Mauro","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1280","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.2217\/nnm-2016-0167","article-title":"Targeting cells of the immune system: mannosylated HPMA\u2013LMA block-copolymer micelles for targeting of dendritic cells","volume":"11","author":"Mohr","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1285","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/mabi.201400417","article-title":"Directed interactions of block Copolypept(o)ides with mannose-binding receptors: PeptoMicelles targeted to cells of the innate immune system","volume":"15","author":"Heller","year":"2015","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1290","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/21691401.2017.1414054","article-title":"Efaverinz and nano-gold-loaded mannosylated niosomes: a host cell-targeted topical HIV-1 prophylaxis via thermogel system","volume":"46","author":"Malik","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1295","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1517\/17425247.5.6.703","article-title":"Mannose-targeted systems for the delivery of therapeutics","volume":"5","author":"Irache","year":"2008","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1300","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1023\/A:1011070425430","article-title":"Affinity enhancement by multivalent lectin\u2013carbohydrate interaction","volume":"17","author":"Lee","year":"2000","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1305","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1517\/17425247.5.6.703","article-title":"Mannose-targeted systems for the delivery of therapeutics","volume":"5","author":"Irache","year":"2008","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1310","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.4049\/jimmunol.178.8.4975","article-title":"Mannose receptor expression and function define a new population of murine dendritic cells","volume":"178","author":"McKenzie","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1315","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1462-5822.2005.00506.x","article-title":"How C-type lectins detect pathogens","volume":"7","author":"Cambi","year":"2005","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1320","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/slct.201600007","article-title":"Synthesis of mannose-cholesterol conjugates for targeted liposomal drug delivery","volume":"1","author":"Nguyen","year":"2016","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1325","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jconrel.2009.12.016","article-title":"Intratracheally instilled mannosylated cationic liposome\/NF\u03baB decoy complexes for effective prevention of LPS-induced lung inflammation","volume":"149","author":"Wijagkanalan","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1330","doi-asserted-by":"crossref","first-page":"19087","DOI":"10.1074\/jbc.274.27.19087","article-title":"Mannose polyethylenimine conjugates for targeted DNA delivery into dendritic cells","volume":"274","author":"Diebold","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1335","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1007\/s13346-021-01003-7","article-title":"Mannose-conjugated chitosan nanoparticles for delivery of rifampicin to Osteoarticular tuberculosis","volume":"11","author":"Prabhu","year":"2021","journal-title":"Drug Deliv Transl. Res."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1340","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1039\/B600060F","article-title":"Mannose\u2013pepstatin conjugates as targeted inhibitors of antigen processing","volume":"4","author":"Free","year":"2006","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.carres.2012.08.001","article-title":"Synthesis and cytotoxicity of some d-mannose click conjugates with aminobenzoic acid derivatives","volume":"361","author":"Hradilov\u00e1","year":"2012","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1350","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1021\/acsinfecdis.0c00407","article-title":"Mannose conjugated polymer targeting P. Aeruginosa biofilms","volume":"6","author":"Limqueco","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1355","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3390\/pharmaceutics12100915","article-title":"Mannose-decorated dendritic polyglycerol nanocarriers drive antiparasitic drugs to leishmania infantum-infected macrophages","volume":"12","author":"Vossen","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1360","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/cbic.202000538","article-title":"Multivalent, stabilized mannose-6-phosphates for the targeted delivery of toll-like receptor ligands and peptide antigens","volume":"22","author":"Reintjens","year":"2021","journal-title":"ChemBioChem"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1365","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202200061","article-title":"Synthetic neoglycoconjugates of hepta- and nonamannoside ligands for eliciting oligomannose-specific HIV-1-neutralizing antibodies","volume":"23","author":"Cattin","year":"2022","journal-title":"ChemBioChem"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1370","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1002\/chem.201605236","article-title":"Mannose-functionalized hyperbranched polyglycerol loaded with zinc porphyrin: investigation of the multivalency effect in antibacterial photodynamic therapy","volume":"23","author":"Staegemann","year":"2017","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1375","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.111378","article-title":"Mannose-functionalized antigen nanoparticles for targeted dendritic cells, accelerated endosomal escape and enhanced MHC-I antigen presentation","volume":"197","author":"Pei","year":"2021","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1380","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.00980","article-title":"Optimization of the linker length of mannose-cholesterol conjugates for enhanced mRNA delivery to dendritic cells by liposomes","volume":"9","author":"Wang","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1385","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijbiomac.2017.12.143","article-title":"Mannose-conjugated curcumin-chitosan nanoparticles: efficacy and toxicity assessments against Leishmania donovani","volume":"111","author":"Chaubey","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1390","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ymthe.2022.09.009","article-title":"Combination treatment of mannose and GalNAc conjugated small interfering RNA protects against lethal Marburg virus infection","volume":"31","author":"Ye","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1395","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jconrel.2022.09.038","article-title":"Mannose in vaccine delivery","volume":"351","author":"Nahar","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1400","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.colsurfb.2015.01.005","article-title":"Mannosylated and lipid A-incorporating cationic liposomes constituting microneedle arrays as an effective oral mucosal HBV vaccine applicable in the controlled temperature chain","volume":"126","author":"Wang","year":"2015","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1405","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/s41565-019-0512-0","article-title":"Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulators","volume":"14","author":"Conniot","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1410","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1021\/acs.molpharmaceut.9b01082","article-title":"Peptide glycodendrimers as potential vaccines for olive pollen allergy","volume":"17","author":"Bened\u00e9","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1415","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1021\/mp5005492","article-title":"Mannosylated polyion complexes for in vivo gene delivery into CD11c + dendritic cells","volume":"12","author":"Raviv","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1420","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1016\/j.celrep.2017.02.003","article-title":"Vaccine elicitation of high mannose-dependent neutralizing antibodies against the V3-glycan broadly neutralizing epitope in nonhuman primates","volume":"18","author":"Saunders","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1425","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3390\/v6020391","article-title":"Pseudo-mannosylated DC-SIGN ligands as potential adjuvants for HIV vaccines","volume":"6","author":"Berzi","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1430","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.2147\/IJN.S43827","article-title":"Enhanced immune response against HIV-1 induced by a heterologous DNA prime-adenovirus boost vaccination using mannosylated polyethyleneimine as DNA vaccine adjuvant","author":"Sun","year":"2013","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1435","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2017.00445","article-title":"Intranasal vaccination with Mannosylated chitosan formulated DNA vaccine enables robust IgA and cellular response induction in the lungs of mice and improves protection against pulmonary mycobacterial challenge","volume":"7","author":"Wu","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2016.01.054","article-title":"Enhanced non-inflammasome mediated immune responses by mannosylated zwitterionic-based cationic liposomes for HIV DNA vaccines","volume":"85","author":"Qiao","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1445","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3390\/v6020391","article-title":"Pseudo-mannosylated DC-SIGN ligands as potential adjuvants for HIV vaccines","volume":"6","author":"Berzi","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1450","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1021\/acschembio.9b00987","article-title":"C -Mannosyl lysine for solid phase assembly of mannosylated peptide conjugate cancer vaccines","volume":"15","author":"Hogervorst","year":"2020","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1455","doi-asserted-by":"crossref","first-page":"4784","DOI":"10.1016\/j.vaccine.2009.05.091","article-title":"Immunoadjuvant capacity of flagellin and mannosamine-coated poly(anhydride) nanoparticles in oral vaccination","volume":"27","author":"Salman","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1460","unstructured":"ClinicalTrials.gov, ClinicalTrials.gov, ClinicalTrials (2023). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01068509 (accessed September 21, 2023)."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1465","author":"ClinicalTrials.gov"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1470","unstructured":"ClinicalTrials.gov, ClinicalTrials.gov, ClinicalTrials.Gov (n.d.). @misc%7BClinicalTrials.gov,%0Aauthor = %7BClinicalTrials.gov%7D,%0Abooktitle = %7B2023%7D,%0Amendeley-groups = %7BSatish sir\/Mannose%7D,%0Atitle = %7B%7BClinicalTrials.gov%7D%7D,%0Aurldate = %7B21-09-2023%7D%0A%7D%0A (accessed September 21, 2023)."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1475","author":"ClinicalTrials.gov"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1480","series-title":"ClinicalTrials.gov, ClinicalTrials.Gov","author":"ClinicalTrials.gov","year":"2023"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1485","series-title":"ClinicalTrials.gov, ClinicalTrials.Gov","author":"ClinicalTrials.gov","year":"2023"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1490","series-title":"ClinicalTrials.gov, ClinicalTrials","author":"ClinicalTrials.gov","year":"2023"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1495","series-title":"ClinicalTrials.gov, ClinicalTrials.Gov","author":"ClinicalTrials.gov","year":"2023"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1500","series-title":"ClinicalTrials.gov","author":"ClinicalTrials.gov","year":"2023"},{"issue":"6","key":"10.1016\/j.jconrel.2024.06.002_bb1505","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1586\/erv.11.20","article-title":"CDX-1307: a novel vaccine under study as treatment for muscle-invasive bladder cancer","volume":"10","author":"Morse","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1510","series-title":"Single DermaVir Immunization in HIV-1 Infected Patients on HAART (GIHU004)","author":"Denes Banhegyi","year":"2013"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1515","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035416","article-title":"Single DermaVir immunization: dose-dependent expansion of precursor\/memory T cells against all HIV antigens in HIV-1 infected individuals","volume":"7","author":"Lisziewicz","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1520","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00262-012-1369-3","article-title":"Proposed mechanism of off-target toxicity for antibody\u2013drug conjugates driven by mannose receptor uptake","volume":"62","author":"Gorovits","year":"2013","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1525","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jconrel.2020.01.046","article-title":"Mannosylated nanocarriers mediated site-specific drug delivery for the treatment of cancer and other infectious diseases: a state of the art review","volume":"320","author":"Patil","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.06.002_bb1530","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2022041853","article-title":"A review on recent advances in mannose-functionalized targeted Nanocarrier delivery systems in cancer and infective therapeutics","volume":"40","author":"Suvarna","year":"2023","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1535","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/01.rli.0000135980.08491.33","article-title":"Macrophage imaging in central nervous system and in carotid atherosclerotic plaque using Ultrasmall superparamagnetic Iron oxide in magnetic resonance imaging","volume":"39","author":"Corot","year":"2004","journal-title":"Investig. Radiol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1540","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1002\/eji.1830270942","article-title":"Mannose receptor-mediated uptake of antigens strongly enhances HLA class II-restricted antigen presentation by cultured dendritic cells","volume":"27","author":"Tan","year":"1997","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1545","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nri2302","article-title":"Setting the stage: host invasion by HIV","volume":"8","author":"Hladik","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2024.06.002_bb1550","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1080\/21645515.2015.1105415","article-title":"Dendritic cell targeted vaccines: recent progresses and challenges","volume":"12","author":"Chen","year":"2016","journal-title":"Hum. Vaccin. Immunother."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924003444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924003444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T15:30:22Z","timestamp":1721921422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365924003444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":310,"alternative-id":["S0168365924003444"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.06.002","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current status of mannose receptor-targeted drug delivery for improved anti-HIV therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}